ANNE AMBS: Open Payments
NPI 1285150441 · PLEASANT GARDEN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,802 in 153 payments from 27 companies in 2025. Trend: 2023 $2,882 · 2024 $3,684 · 2025 $3,802
Food & beverage: $3,721Education: $59Consulting: $22
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $824 |
| Regeneron Healthcare Solutions, Inc. | 20 | $791 |
| Amgen Inc. | 24 | $378 |
| GENZYME CORPORATION | 9 | $227 |
| Novartis Pharmaceuticals Corporation | 10 | $195 |
| ABBVIE INC. | 6 | $149 |
| GlaxoSmithKline, LLC. | 8 | $141 |
| Genentech USA, Inc. | 6 | $128 |
| CSL Behring | 5 | $128 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $108 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, BREZTRI, RINVOQ, NUCALA, Xolair, NEFFY.
Industry payments across NC — which companies pay providers there.
